CR treatment disrupts the interconnected signaling network, helping prevent chronic inflammatory and fibrotic DN responses.Network Pharmacological analysis of CR discovered that the IL-6 signaling pathway (WP Term ID: WP364) also serves as a vital pathway in DN development because it highlights the importance of persistent inflammation in disease progression. This evidence concerns the gene IL6 and liver dysplastic nodule.